Nanocarriers enhance the transdermal bioavailability of resveratrol: In-vitro and in-vivo study

被引:44
|
作者
Tsai, Ming-Jun [1 ,2 ]
Lu, I-Ju [3 ]
Fu, Yaw-Syan [4 ]
Fang, Yi-Ping [3 ]
Huang, Yaw-Bin [3 ]
Wu, Pao-Chu [3 ]
机构
[1] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan
[2] China Med Univ, Coll Med, Sch Med, Yuh Der Rd, Taichung 404, Taiwan
[3] Kaohsiung Med Univ, Sch Pharm, 100 Shih Chuan 1st Rd, Kaohsiung 807, Taiwan
[4] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, 100 Shih Chuan 1st Rd, Kaohsiung 807, Taiwan
关键词
Resveratrol; Topical application; Transdermal amount; Deposition amount; Skin irritation; Stability; SKIN PERMEATION; TOPICAL APPLICATION; DELIVERY; MICROEMULSION; NANOPARTICLES; LIPOSOMES; POLYPHENOLS; METABOLISM; CARRIERS; SYSTEMS;
D O I
10.1016/j.colsurfb.2016.09.045
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The aim of this study was to develop and assess the potential of nanostructured emulsion carriers for resveratrol topical application. Different compositions of resveratrol-loaded nanostructured emulsions were prepared using different types and amounts of surfactants and oily phases (isopropyl myristate and caproyl 90). The produced nanostructured emulsions were within the nanosized range 23.4-422.2 nm with low viscosity range 2.15-17.53 cps. The transdermal amount and deposition amount in the skin after 24 applications of resveratrol-loaded nanostructured emulsion were significantly increased about 896.2-fold and 10.2-fold respectively, when compared to the drug-saturated solution-treated group. Nanostructured emulsion containing IPM and low amounts of mixed surfactant of Tween80/Span 20 showed highest permeation capacity. In vivo study showed that the plasma concentration of resveratrol could be maintained at high levels for a long time after topical application of drug-loaded nanostructured emulsion. The histological examination demonstrated that the free drug- and drug-loaded nanostructured emulsion demonstrated considerably less irritation than the standard irritation group (0.8% paraformaldehyde-treated). The residual contents of resveratrol in the tested formulations after 3 months of storage at 25 degrees C and 40 degrees C were more than 99.97 +/- 3.90%. The results of present work confirm the high potential of nanostructured emulsion as carriers for drug topical application. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:650 / 656
页数:7
相关论文
共 50 条
  • [1] Curcumin loaded ethosomes for transdermal application: Formulation, optimization, in-vitro and in-vivo study
    Pathan, Inayat B.
    Jaware, Bhaktraj P.
    Shelke, Santosh
    Ambekar, Wahid
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 44 : 49 - 57
  • [2] Cilnidipine loaded transfersomes for transdermal application: Formulation optimization, in-vitro and in-vivo study
    Khatoon, Karishma
    Rizwanullah, Md
    Amin, Saima
    Mir, Showkat R.
    Akhter, Sohail
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 54
  • [3] Bioavailability and In-vivo Transdermal Delivery of Haloperidol
    Elgorashi, Abubakr S.
    SUDAN JOURNAL OF MEDICAL SCIENCES, 2009, 4 (01): : 47 - 54
  • [4] IN-VITRO AND IN-VIVO
    不详
    NATURE, 1972, 239 (5368) : 132 - &
  • [5] Microemulsion based Transdermal Gels of Isradipine to Enhance Bioavailability: In vitro and In vivo Evaluation
    Madikattu, Kalpana
    Naidu, K. V. S.
    Srisailam, K.
    ASIAN JOURNAL OF PHARMACEUTICS, 2016, 10 (01) : S23 - S30
  • [6] Adoption of polymeric micelles to enhance the oral bioavailability of dexibuprofen: formulation, in-vitro evaluation and in-vivo pharmacokinetic study in healthy human volunteers
    Abdelbary, Ghada
    Makhlouf, Amal
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2014, 19 (06) : 717 - 727
  • [7] IN-VITRO AND IN-VIVO STUDY OF CARBOCROMEN HYDROLYSIS
    ARMAND, J
    BAZAUGOUR, R
    BADINAND, A
    ANNALES PHARMACEUTIQUES FRANCAISES, 1973, 31 (05): : 369 - 374
  • [8] In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic
    Takasuga, Shinri
    Yamamoto, Rie
    Mafune, Shoichi
    Sutoh, Chiyo
    Kominami, Katsuya
    Yoshida, Yoshimasa
    Ito, Masao
    Kinoshita, Mine
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 63 (11) : 1437 - 1445
  • [9] COMPARATIVE IN-VITRO AND IN-VIVO BIOAVAILABILITY OF NAPROXEN FROM TABLET AND CAPLET FORMULATIONS
    CHARLES, BG
    MOGG, GAG
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (02) : 121 - 128
  • [10] FROM IN-VITRO TO IN-VIVO
    FANTIN, B
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 757 - 758